Declan Murphy, MD | Authors

Articles

Exploring PSMA Therapies in Prostate Cancer

December 03, 2020

Declan Murphy, MD, discusses the current interest in using PSMA, following the FDA’s approval of Gallium 68 PSMA-11, which marks the first ever drug for PET imaging of PSMA-positive lesions in men with prostate cancer.